Annual Drug Patent Expirations for LOSEASONIQUE
Loseasonique is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for LOSEASONIQUE.
This drug has sixty patent family members in twenty-two countries.
The generic ingredient in LOSEASONIQUE is ethinyl estradiol; levonorgestrel. Two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
